Health equity, a fundamental human right, remains elusive for many. As health communicators, we play a crucial role in addressing these disparities, bridging gaps and supporting underserved ...
GSK’s fully liquid presentation of its meningococcal vaccine Menveo has been approved by the European Commission (EC) to ...
The development of all treatments, including vaccines, is dependent on people taking part in clinical trials but this can be ...
A UK study has shown that a drug currently used to treat severe asthma could be re-purposed for use in emergency settings, ...
Galderma’s nemolizumab has been shown to improve the core signs and symptoms of prurigo nodularis, according to phase 3 ...
Novartis’ Kisqali (ribociclib) has been approved by the European Commission (EC) to reduce the risk of disease recurrence in ...
GSK’s linerixibat has shown promising results in a late-stage trial of primary biliary cholangitis (PBC) patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback